Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Boston Scientific Corp., profitability ratios
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Boston Scientific Corp. gross profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Boston Scientific Corp. operating profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Boston Scientific Corp. net profit margin ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Boston Scientific Corp. ROE improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Boston Scientific Corp. ROA improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Gross Profit Margin
Boston Scientific Corp., gross profit margin calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Gross profit | 8,727) | 8,177) | 6,448) | 7,620) | 7,011) | |
| Net sales | 12,682) | 11,888) | 9,913) | 10,735) | 9,823) | |
| Profitability Ratio | ||||||
| Gross profit margin1 | 68.81% | 68.78% | 65.05% | 70.98% | 71.37% | |
| Benchmarks | ||||||
| Gross Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 51.54% | 52.21% | 50.49% | 52.46% | — | |
| Cigna Group | 12.44% | 12.41% | 14.43% | 15.57% | — | |
| CVS Health Corp. | 16.62% | 17.48% | 18.01% | 17.41% | — | |
| Elevance Health Inc. | 16.79% | 17.09% | 19.71% | 18.77% | — | |
| Intuitive Surgical Inc. | 67.44% | 69.32% | 65.65% | 69.45% | — | |
| Medtronic PLC | 67.98% | 65.19% | 67.41% | 70.04% | 69.77% | |
| Shockwave Medical Inc. | 86.73% | 82.53% | 69.03% | 60.03% | — | |
| UnitedHealth Group Inc. | 24.09% | 23.60% | 25.62% | 23.19% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Gross profit margin = 100 × Gross profit ÷ Net sales
= 100 × 8,727 ÷ 12,682 = 68.81%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Boston Scientific Corp. gross profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Operating Profit Margin
Boston Scientific Corp., operating profit margin calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Operating income (loss) | 1,649) | 1,199) | (80) | 1,518) | 1,506) | |
| Net sales | 12,682) | 11,888) | 9,913) | 10,735) | 9,823) | |
| Profitability Ratio | ||||||
| Operating profit margin1 | 13.00% | 10.09% | -0.81% | 14.14% | 15.33% | |
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 19.16% | 19.56% | 15.48% | 14.21% | — | |
| Cigna Group | 4.69% | 4.60% | 5.12% | 5.31% | — | |
| CVS Health Corp. | 2.41% | 4.54% | 5.19% | 4.69% | — | |
| Elevance Health Inc. | 4.94% | 5.15% | 4.97% | 5.49% | — | |
| Humana Inc. | 4.11% | 3.80% | 6.56% | 4.96% | — | |
| Intuitive Surgical Inc. | 25.35% | 31.89% | 24.09% | 30.69% | — | |
| Medtronic PLC | 18.15% | 14.89% | 16.57% | 20.51% | 22.20% | |
| Shockwave Medical Inc. | 25.35% | -0.37% | -96.86% | -120.76% | — | |
| UnitedHealth Group Inc. | 8.83% | 8.40% | 8.76% | 8.19% | — | |
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 6.23% | 6.68% | 7.03% | 6.88% | — | |
| Operating Profit Margin, Industry | ||||||
| Health Care | 13.22% | 13.18% | 10.47% | 12.44% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Operating profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 1,649 ÷ 12,682 = 13.00%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Boston Scientific Corp. operating profit margin ratio improved from 2020 to 2021 and from 2021 to 2022. |
Net Profit Margin
Boston Scientific Corp., net profit margin calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income (loss) | 698) | 1,041) | (82) | 4,700) | 1,671) | |
| Net sales | 12,682) | 11,888) | 9,913) | 10,735) | 9,823) | |
| Profitability Ratio | ||||||
| Net profit margin1 | 5.50% | 8.76% | -0.83% | 43.78% | 17.01% | |
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 15.88% | 16.42% | 12.99% | 11.56% | — | |
| Cigna Group | 3.72% | 3.11% | 5.31% | 3.35% | — | |
| CVS Health Corp. | 1.29% | 2.72% | 2.68% | 2.59% | — | |
| Elevance Health Inc. | 3.87% | 4.46% | 3.78% | 4.66% | — | |
| Humana Inc. | 3.03% | 3.54% | 4.43% | 4.20% | — | |
| Intuitive Surgical Inc. | 21.25% | 29.85% | 24.33% | 30.80% | — | |
| Medtronic PLC | 15.90% | 11.97% | 16.56% | 15.16% | 10.36% | |
| Shockwave Medical Inc. | 44.10% | -3.85% | -96.92% | -119.06% | — | |
| UnitedHealth Group Inc. | 6.25% | 6.06% | 6.03% | 5.76% | — | |
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 4.62% | 4.96% | 5.20% | 4.84% | — | |
| Net Profit Margin, Industry | ||||||
| Health Care | 10.26% | 10.89% | 7.77% | 10.20% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Net profit margin = 100 × Net income (loss) ÷ Net sales
= 100 × 698 ÷ 12,682 = 5.50%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Boston Scientific Corp. net profit margin ratio improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Return on Equity (ROE)
Boston Scientific Corp., ROE calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income (loss) | 698) | 1,041) | (82) | 4,700) | 1,671) | |
| Stockholders’ equity | 17,573) | 16,622) | 15,326) | 13,877) | 8,726) | |
| Profitability Ratio | ||||||
| ROE1 | 3.97% | 6.26% | -0.54% | 33.87% | 19.15% | |
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Abbott Laboratories | 18.90% | 19.75% | 13.71% | 11.86% | — | |
| Cigna Group | 14.86% | 11.39% | 16.81% | 11.26% | — | |
| CVS Health Corp. | 5.84% | 10.54% | 10.35% | 10.39% | — | |
| Elevance Health Inc. | 16.59% | 16.93% | 13.77% | 15.15% | — | |
| Humana Inc. | 18.33% | 18.24% | 24.53% | 22.49% | — | |
| Intuitive Surgical Inc. | 11.98% | 14.32% | 10.90% | 16.69% | — | |
| Medtronic PLC | 9.59% | 7.01% | 9.44% | 9.25% | 6.12% | |
| Shockwave Medical Inc. | 42.24% | -3.78% | -29.11% | -26.53% | — | |
| UnitedHealth Group Inc. | 25.87% | 24.09% | 23.52% | 24.02% | — | |
| ROE, Sector | ||||||
| Health Care Equipment & Services | 15.40% | 15.04% | 15.13% | 14.24% | — | |
| ROE, Industry | ||||||
| Health Care | 22.52% | 23.00% | 16.14% | 21.17% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × 698 ÷ 17,573 = 3.97%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Boston Scientific Corp. ROE improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |
Return on Assets (ROA)
Boston Scientific Corp., ROA calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income (loss) | 698) | 1,041) | (82) | 4,700) | 1,671) | |
| Total assets | 32,469) | 32,229) | 30,777) | 30,565) | 20,999) | |
| Profitability Ratio | ||||||
| ROA1 | 2.15% | 3.23% | -0.27% | 15.38% | 7.96% | |
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Abbott Laboratories | 9.31% | 9.40% | 6.20% | 5.43% | — | |
| Cigna Group | 4.63% | 3.46% | 5.44% | 3.28% | — | |
| CVS Health Corp. | 1.82% | 3.39% | 3.11% | 2.98% | — | |
| Elevance Health Inc. | 5.86% | 6.26% | 5.28% | 6.21% | — | |
| Humana Inc. | 6.52% | 6.61% | 9.63% | 9.31% | — | |
| Intuitive Surgical Inc. | 10.19% | 12.58% | 9.50% | 14.17% | — | |
| Medtronic PLC | 5.54% | 3.87% | 5.28% | 5.16% | 3.40% | |
| Shockwave Medical Inc. | 33.43% | -2.64% | -24.15% | -22.04% | — | |
| UnitedHealth Group Inc. | 8.19% | 8.15% | 7.81% | 7.96% | — | |
| ROA, Sector | ||||||
| Health Care Equipment & Services | 5.65% | 5.62% | 5.60% | 5.17% | — | |
| ROA, Industry | ||||||
| Health Care | 8.35% | 8.24% | 5.46% | 7.22% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 698 ÷ 32,469 = 2.15%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Boston Scientific Corp. ROA improved from 2020 to 2021 but then slightly deteriorated from 2021 to 2022. |